The Angiogenesis Foundation, is a United States 501(c)(3) nonprofit organization established to study angiogenesis.
History The Angiogenesis Foundation was founded in 1994 in Cambridge, Massachusetts. The foundation developed a therapy for canine cancer, called the Navy Protocol. This treatment works by starving the tumor of its blood supply. In 2004, they helped publicly launch the first antiangiogenic therapy for cancer, bevacizumab, starting with colorectal cancer.Colon cancer drug seen as long awaited victory, February 26, 2004 In 2010, the president and co-founder of the Angiogenesis Foundation, William Li, gave a well-received presentation at the TED conference on cancer prevention through antiangiogenic nutrition.
Co-founder Dr. William Li won the 2024 Dr. Andrew von Eschenbach Award for his work in angiogenesis.The Angiogenesis Foundation Chief Executive Officer Dr. William Li Was Honored As the Inaugural Recipient of the Dr. Andrew Von Eschenbach Award
References
External links
"The Angiogenesis Foundation Receives Highest Rating from Charity Navigator" - The Providence Journal, Nov. 7, 2013.